Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Roderick MacKinnon Net Worth & Insider Trades

Roderick MacKinnon - Director, Flex Pharma, Inc

As of July 27, 2017

What is Roderick MacKinnon's Net Worth?

The current estimated net worth of Flex Pharma, Inc's Director, Roderick MacKinnon, is estimated to be about $3.03M . Roderick MacKinnon owns about 431,277 units of Flex Pharma, Inc common stock. In the last 2 years at Flex Pharma, Inc, Roderick MacKinnon has sold an estimated value of $0 worth.

What is Roderick MacKinnon's Past Insider Trading?

Roderick MacKinnon's largest purchase order was 10,000 units , worth over $70.26K on March 15, 2016. In total, Roderick MacKinnon has made about 4 transactions over 2 years of their time at Flex Pharma, Inc. Roderick MacKinnon usually trades in July, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Roderick MacKinnon

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Roderick MacKinnon's' Mailing Address?

  • Mailing address is C/o Flex Pharma, Inc. 800 Boylston Street, 24th Floor Boston MA 02119 MA

What are Flex Pharma, Inc's Past Insider Trades?

Flex Pharma, Inc's most recent insider trade came on January 10, 2019 by Boston Foundation Inc who sold 337,000 units worth $123.85K . In the last 4 years, insiders at Flex Pharma, Inc have sold an estimated value of $6.11M and bought an estimated value of $6.85M worth of shares. Insider trading is most common in July, with the busiest year in 2015. The most active traders at the company are Christoph H Westphal,  Barton Peter Hutt, Director,  and John McCabe, Chief Financial Officer .

Flex Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...